Sd-RAB for the Diagnosis of PPLs

Launched by SHANGHAI CHEST HOSPITAL · Dec 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new robotic-assisted system designed to help doctors diagnose peripheral pulmonary lesions, which are abnormal growths in the lungs that may be cancerous. The goal is to see if this innovative technology is safe and effective for patients who need a biopsy, a procedure to take a small sample of tissue for testing.

To participate in this study, you must be over 18 years old and have a specific type of lung lesion identified through imaging tests. It's important that you are generally well and can follow medical advice. Unfortunately, if you have certain conditions that would make a bronchoscopy unsafe, or if you have other lesions in your lungs, you won't be eligible for this trial. If you join, you'll be among the first to test this new technology, and the researchers will closely monitor your experience to ensure your safety throughout the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients older than 18 years old.
• • 2. Chest imaging shows the presence of peripheral pulmonary lesions (defined as those lesions that are surrounded by pulmonary parenchyma and located below the segmental bronchus), which are suspected to be malignant and require a non-surgical biopsy.
• • 3. Patients have good medical adherence and signed informed consent.
• Exclusion Criteria:
• • 1. Contraindications for bronchoscopy.
• • 2. Presence of concomitant endobronchial lesion during the bronchoscopy procedure.
• • 3. The investigators believe that patient has other conditions that are not suitable for the study.